Gossamer Bio Inc (NASDAQ:GOSS)’s traded shares stood at 2.42 million during the last session, with the company’s beta value hitting 1.87. At the close of trading, the stock’s price was $1.16, to imply an increase of 0.87% or $0.01 in intraday trading. The GOSS share’s 52-week high remains $1.55, putting it -33.62% down since that peak but still an impressive 56.9% since price per share fell to its 52-week low of $0.50.
Analysts have given a consensus recommendation of Buy for Gossamer Bio Inc (GOSS), translating to a mean rating of 1.44. Of 10 analyst(s) looking at the stock, 0 analyst(s) give GOSS a Sell rating. 0 of those analysts rate the stock as Overweight while 3 advise Hold as 7 recommend it as a Buy.
Gossamer Bio Inc (NASDAQ:GOSS) trade information
After registering a 0.87% upside in the last session, Gossamer Bio Inc (GOSS) has traded red over the past five days. The 5-day price performance for the stock is 10.48%, and 29.64% over 30 days. With these gigs, the year-to-date price performance is 28.23%.
The extremes give us $2 and $5 for target low and target high price respectively. As such, GOSS has been trading -331.03% off suggested target high and -72.41% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 40.29% for the past 5-year period. While 2025 is set for a -168.69% return in earnings, projections for the next 5 years are at 15.97% annually.
GOSS Dividends
Gossamer Bio Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is ARTAL GROUP S.A. with 13.31 million shares, or about 5.8832% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $11.99 million.
We also have Fidelity Select Portfolios-Biotechnology Portfolio and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Gossamer Bio Inc (GOSS) shares. Going by data provided on Mar 31, 2025 , Fidelity Select Portfolios-Biotechnology Portfolio holds roughly 7.57 shares. This is just over 3.33% of the total shares, with a market valuation of $8.79 million. Data from the same date shows that the other fund manager holds a little less at 6.76, or 2.98% of the shares, all valued at about 7.85 million.
